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Brief Research Reportsappealing option, yet they may be too limited in flow and
durability.2 The AA-LVAD combines the benefit of a
relatively quick insertion with sufficient circulatory
support for restoration of end-organ function4 and avoids
the hazards of resternotomy and invasive surgery.
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J Thorac Cardiovasc Surg. 2003;125:855-62.Are preoperative B-type natriuretic peptide levels associated with
outcome after pulmonary artery banding and the double switch
operation in patients with congenitally corrected transposition of
the great arteries: A pilot studyDanton S. Char, MD,a Stephen C. Shiboski, PhD,b Frank L. Hanley, MD,c and Jeffrey R. Fineman, MD,d
Stanford and San Francisco, CalifPulmonary artery banding (PAB) for ventricular training fol-
lowed by the double switch operation (DSO) is an attractive
surgical option for suitable patients with congenitally
corrected transposition of the great arteries (ccTGA). After
repair, the systemic circulation is supported by the morpho-
logic left ventricle (LV). Adoption of DSO was driven by
the poor natural history of the systemic right ventricle (RV)
and successful outcomes with DSO have been reported since
the mid-1990s.1 Although mortality after these operations is
low with careful patient selection, the accurate prediction of
adverse postoperative outcomes is difficult, and there remains
an unpredictable risk of morbidity, takedown or reoperation.2
Recent studies have demonstrated that perioperative
changes in B-type natriuretic peptide (BNP) levels maypredict postoperative morbidity and mortality after surgery
for the repair or palliation of congenital cardiac defects.3
However, the potential usefulness of preoperative BNP
levels as predictors of postoperative outcomes in patients
undergoing repair for ccTGA has not been investigated.
This pilot study hypothesized that preoperative BNP levels
could be associatedwith unexpected outcomes after PAB and
DSO in patients otherwise deemed to be suitable operative
candidates on the basis of standard preoperative clinical,
echocardiographic, and hemodynamic assessments.
MATERIALS AND METHODS
Design and Participants
A pilot prospective cohort study was undertaken at Lucile Packard
Children’s Hospital Heart Center from November 2011 to November
2013. Eligible participants included all patients with ccTGA undergoing
either PAB or DSO. Management followed standard institutional practices.
Informed consent from the patients or their guardians was obtained before
enrollment. The Stanford University Medical Center Institutional Review
Board approved the study (IRB 22458).
Blood samples were obtained from a venous or arterial catheter less than
24 hours preoperatively and were assayed using a commercially available
fluorescence immunoassay (Triage Meter Plus; Biosite Diagnostic, San
Diego, Calif).
Outcome
The end point was a composite of adverse outcomes including death,
cardiac arrest, need for extracorporeal cardiopulmonary life support or
emergency reoperation.
Analysis
The 2-sided Fisher exact test was used to evaluate the association
between increased BNP level (>300 pg/mL) and the binary compositegery c November 2014
TABLE 1. Demographics, preoperative BNP, and outcomes
Age Weight (kg) Diagnosis Surgery performed
Preoperative
BNP (pg/mL) Outcome
24 y 73.6 ccTGA, dextroversion after VSD
closure,
and TV replacement
PAB 48.1
3 y 11.2 ccTGA, displastic ebsteinoid TV
with severe TR,
and LV dilation
PAB 366 Emergency reoperation:
PAB loosening
15 y 66.5 ccTGA and PFO PAB 17.7
14 mo 10.7 Situs inversus, ccTGAwith
pulmonary atresia
Bidirectional Glenn 14.9
36 y 90.5 ccTGA, VSD PAB; conduit change 26.1
14 y 60.6 ccTGA Transplant 94.5
7 mo 8.1 ccTGA, severe TR PAB 331 Cardiac arrest
16 mo 9.4 ccTGA, subpulmonic stenosis,
large VSD
DSO 8.3
4 y 12.7 ccTGA, displastic ebsteinoid TV
with severe TR,
and LV dilation
DSO 102
6 y 20.9 ccTGA, prior PAB DSO 18.5
18 mo 12.4 ccTGA, VSD DSO 34.2
16 y 72.1 ccTGA prior PAB PAB 11.5
6 y 20 ccTGA, prior PAB DSO 38.1
BNP, B-type natriuretic peptide; ccTGA, congenitally corrected transposition of the great arteries; VSD, ventricular septal defect; TV, tricuspid valve; PAB, pulmonary artery
banding; TR, tricuspid regurgitation; LV, left ventricle; PFO, patent foramen ovale; DSO, double switch operation.
Brief Research Reportsadverse outcome. Exact logistic regression was used to estimate the
corresponding odds ratio and 95% confidence interval. Statistical analyses
were performed using Stata 13 (StataCorp LP, College Station, Tex).RESULTS
Fifteen patients were approached and 13 were enrolled.
Six patients underwent PAB and 5 underwent DSO. Two
patients were excluded from the analysis: 1 who underwent
a Glenn operation and 1 who underwent transplantation
(Table 1).
Two patients experienced an adverse outcome: 1 devel-
oped severe hypotension requiring emergency reoperationFIGURE 1. Distribution of preoperative BNP level (pg/mL) by outcome.
BNP, B-type natriuretic peptide.
The Journal of Thoracic and Carto loosen the pulmonary artery (PA) band; 1 had an
intraoperative cardiac arrest, treated successfully with
resuscitation measures. None of the patients died. Both
adverse outcomes were in patients undergoing PAB.
Preoperative BNP levels ranged from 8.3 to 366 pg/mL.
The 2 patients with adverse outcome had preoperative BNP
levels of 366 pg/mL and 331 pg/mL. All other patients had
preoperative BNP levels less than 102 pg/mL. BNP was
strongly associated with adverse outcome, particularly
BNP greater than 300 pg/mL (Figure 1). All patients met
criteria for morphologic LV readiness for DSO or need
for further retraining by PAB by clinical evaluation,
assessment of LV ejection fraction and degree of mitral
regurgitation measured by echocardiography, LV mass
measured by magnetic resonance imaging (MRI), and
peak systolic and end diastolic LV pressures measured at
cardiac catheterization.
The observed association between preoperative BNP
greater than 300 pg/mL and adverse outcome was
statistically significant (P¼ .015). The corresponding exact
odds ratio was 22, with a 95% confidence interval of 1.36
to infinity. We were unable to adjust the analysis for
heterogeneity by age, weight, gender, or differences in
cardiac disease.
DISCUSSION
Outcomes after PAB and DSO in patients with ccTGA
have continued to improve since the introduction of the
repair. However, the incidence of in-hospital mortalitydiovascular Surgery c Volume 148, Number 5 2435
Brief Research Reportsremains high, with recent estimates ranging from 2% to
10%.2 In this pilot study, we found that preoperative BNP
levels were markedly higher in patients with adverse
outcomes than in patients with good outcomes in a sample
of patients all thought to be good candidates for surgery by
the current standard preoperative evaluations by cardiac
catheterization, echocardiography, and MRI. Morphologic
LV readiness for DSO or need for further retraining by
PAB was based on 5 criteria at our institution: LV ejection
fraction and degree of mitral regurgitation measured by
echocardiography, LV mass measured by MRI, and peak
systolic and end diastolic LV pressures measured at cardiac
catheterization. Other institutions use similar but not
exactly the same criteria.2,4 Intraoperative PAB tightening
is guided by simultaneous echocardiography and LV and
systemic pressure measurements. A midline sternotomy is
performed to expose the aorta and PA. Minimal dissection
is performed to encircle the proximal main PA with a
silicone rubber band (Dow Corning, Midland, Mich). The
degree of band tightening is guided by simultaneous
transesophageal echocardiographic analysis and direct
proximal PA pressure, LV pressure, and central venous
pressure (CVP, a marker of LV end diastolic pressure)
measurement. As the band is tightened to achieve
successively higher pressures, the LV is monitored for
diminished systolic function. As the LV pressure
increases, transesophageal echocardiographic analysis
demonstrates shift of the intraventricular septum. Often
we see a decrease in tricuspid regurgitation. The goal
after PAB is to get to 100% systemic pressure in the LV,
however we rarely achieve this. We usually achieve
approximately 60% of systemic pressure with our first
banding procedure. Frequently, if we go beyond 60% we
see evidence of LV strain and decreased function as
determined by (1) decreased shortening fraction; (2)
mitral regurgitation; (3) increased CVP (a proxy for LV2436 The Journal of Thoracic and Cardiovascular Surend diastolic pressure); (4) arrhythmias. If any of these
develop, we reduce the tightness of the PAB until these
resolve.
BNP has emerged as a powerful biomarker of impaired
myocardial performance. Landmark studies in adults
demonstrate a cutoff of 100 pg/mL for the diagnosis of
congestive heart failure.5 Levels in congenital heart disease
are much more diverse, and are likely both age and defect
specific. We found that in ccTGA, a BNP level greater
than 300 pg/mL was highly associated with an adverse
outcome, although where the exact cutoff level lies will
require further investigation. This is a meaningful finding
because the exact preoperative hemodynamics that predict
postoperative adverse outcomes in ccTGA remain elusive
and suggest that measurement of BNP blood levels may
be an important adjunct to the current preoperative
evaluation.
The authors gratefully acknowledge Dr Chandra Ramamoorthy’s
support in pursuing this project.References
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